Search Form
First, enter a politician or zip code
Now, choose a category
 

Elijah Cummings' Public Statements on Issue: Business and Consumers

Office: U.S. House (MD) - District 7, Democratic
Date Title
Nov. 17, 2016 Cummings Statement on Charges Against Valeant and Philidor Executives for Kickback Scheme
Nov. 14, 2016 Letter to the Hon. Jason Chaffetz, Chairman, Committee on Oversight and Government Reform - Launch Inquiry into Trump's So-Called "Blind Trust
Nov. 3, 2016 Letter to the Hon. Loretta Lynch, U.S. Attorney General and the Hon. Edith Ramirez, Chairwoman, Federal Trade Commission - Investigate Cost of Diabetes Products
Nov. 3, 2016 Letter to the Honorable Loretta E. Lynch, Attorney General of the United States and the Hon. Edith Ramirez, Chairwoman of the Federal Trade Commission - Request to Investigate Cost of Diabetes Products
Oct. 12, 2016 Letter to the Honorable Barack Obama, President of the United States - Call to Address the Rising Prices of Prescription Drugs
Oct. 7, 2016 Letter to the Hon. Richard Cordray, Dirctor, Consumer Financial Protection Bureau - Develop "Strongest Possible" Rule to Protect Consumers from Predatory Payday Lenders
Sept. 14, 2016 Oversight Committee to Hold Hearing on EpiPen Price Increases
Sept. 13, 2016 Cummings Issues Statement After Meeting with Wells Fargo President About Fraudulent Business Practices
Aug. 29, 2016 Letter to Ms. Heather Bresch, CEO, Mylan N.V. - Dramatic Price Increases for EpiPens
Aug. 25, 2016 Cummings Calls for Oversight Committee Hearing with Both Mylan and Martin Shkreli
Aug. 25, 2016 Cummings Criticizes Mylan's "Discount" for EpiPens
Aug. 10, 2016 Letter to Maria Contreras - Sweet, Administrator of the U.S. Small Business Administration- Maryland Congressional Delegation Urges Federal Support for Howard County After Ellicott City Flood
June 2, 2016 Cummings Lauds CFPB Rule to Protect Small-Dollar Borrowers from Predatory Lenders
June 2, 2016 Ranking Members Cummings, Waters, and Scott Criticize Lawsuit to Undermine Conflict of Interest Rule
May 19, 2016 Payne, Jr., Nearly 90 Members Issue Joint Statement on Verizon Labor Negotiations
May 16, 2016 Cummings Issues Statement on Valeant's Pricing Changes
April 21, 2016 Bonamici, Cummings Introduce Legislation to Stop Abuse, Fraud in Payday Lending
April 12, 2016 Letter to J. Michael Pearson, Chief Executive Officer, Valeant Pharmaceuticals International, Inc. - Demanding Information That Valeant is Withholding From Congress
April 11, 2016 Letter to the Hon. Richard Cordray, Dirctor, Consumer Financial Protection Bureau - GAO Report Highlighting Dramatic Growth of Nonbank Mortgage Servicers
March 31, 2016 Letter to the Hon. Jenny Yang, Chair of the U.S. Equal Employment Opportunity Commission - Fight The Wage Gap
March 28, 2016 Letter to the Honorable Sylvia M. Burwell, Secretary of Health and Human Services and Francis Collins, Director of National Institutes of Health - Act Now on Drug Affordability
March 10, 2016 Letter to J. Michael Pearson, Chief Executive Officer, Valeant Pharmaceuticals International, Inc. - Concerns Regarding Valeant's Lack of Transparency
Feb. 25, 2016 Cummings and Baldwin Introduce Legislation to Expand Protections for Wall Street Whistleblowers
Feb. 25, 2016 Letter to Jacob Lew - Stop Corporate Inversions Following Report on Extent of Pfizer Tax Dodging and Price Gouging
Feb. 4, 2016 Hearing of the House Oversight and Government Reform Committee - Opening Statement of Rep. Cummings, Hearing on "Developments in the Prescription Drug Market: Oversight"
Feb. 2, 2016 Cummings Releases Memos Detailing Internal Corporate Documents on Skyrocketing Drug Prices
Jan. 21, 2016 Tuesday: Oversight Committee Holds Drug Pricing Hearing Long Sought by Cummings
Jan. 1, 2016 Issue Position: Small & Minority Business
Jan. 1, 2016 Issue Position: Small & Minority Business
Dec. 18, 2015 Cummings Issues Statement on Arrest and Resignation of Martin Shkreli
Dec. 17, 2015 Skyrocketing Generic Drug Prices Cost Taxpayers $1.4 Billion, New Report Finds
Dec. 16, 2015 Letter to J. Michael Pearson, Chairman and CEO, Valeant Pharmaceuticals International Inc. - Demanding Documents and Interviews From Valeant Ahead of Oversight Hearing
Dec. 2, 2015 Letter to Martin Shkreli, Chief Executive Officer, Turing Pharmacueticals, LLC - Fake "Price Cut" for Critical Drug
Nov. 19, 2015 Letter to Claudia Rogers, Acting Chief Counsel for Advocacy, Office of Advocacy - Regulation of Small Business
Nov. 16, 2015 Fairness to Veterans for Infrastructure Investment Act of 2015
Nov. 16, 2015 Letter to J. Michael Pearson, Chairman and CEO, Valeant Pharmaceuticals International Inc. - Business Practices
Oct. 9, 2015 Sanders and Cummings Denounce Continued Prescription Drug Price Gouging
Sept. 28, 2015 Letter to Jason Chaffetz, Chairman of the Committee on Oversight and Government Reform, and Bob Goodlatte, Chairman for the Committee on the Judiciary - Call to Subpoena Valeant
Sept. 23, 2015 Letter to Martin Shkreli, CEO of Turing Pharmaceuticals - Price Increases Impact on AIDS Patients
Sept. 22, 2015 Letter to Jason Chaffetz, Chairman of the Committee on Oversight and Government Reform - Hearing on Overnight Price Increases for Life-Saving Drugs
Sept. 21, 2015 Letter to Martin Shkreli, CEO of Turing Pharmaceuticals - Price Increases for Daraprim
Sept. 10, 2015 Sanders, Cummings Introduce Comprehensive Legislation to Lower Soaring Drug Prices
Sept. 10, 2015 Press Conference: Prescription Drug Affordability Act September 10, 2015
Sept. 1, 2015 Efforts by Casey, Wyden, and Cummings Lead to GAO Study of CMS Nursing Home Rating System
Aug. 31, 2015 Letter to David Sutton, CFO of Warner West Pharmacy and Supplies - Insurance Claims for Nutritional Supplements
Aug. 31, 2015 Letter to Larry Merlo, President and CEO of CVS Health - Insurance Claims for Nutritional Supplements
Aug. 27, 2015 Letter to Michael Borkowski, CEO of Access Funding - Predatory Buy-Outs of Structured Settlements
Aug. 26, 2015 Letter to Richard Cordray, Director of the Consumer Financial Protection Bureau - Small Business Lending Data
Aug. 20, 2015 Cummings Issues Detailed Statement on New Report on Skyrocketing Drug Prices
Aug. 20, 2015 Letter to David Daleiden, CEO of the Center for Medical Progress - Planned Parenthood Video
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top